- Home
- AMPY vs BDTX Comparison
AMPY vs BDTX Comparison
Compare AMPY & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- BDTX
- Stock Information
- Founded
- AMPY 2011
- BDTX 2014
- Country
- AMPY United States
- BDTX United States
- Employees
- AMPY N/A
- BDTX N/A
- Industry
- AMPY Oil & Gas Production
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMPY Energy
- BDTX Health Care
- Exchange
- AMPY Nasdaq
- BDTX Nasdaq
- Market Cap
- AMPY 140.8M
- BDTX 132.5M
- IPO Year
- AMPY 2011
- BDTX 2020
- Fundamental
- Price
- AMPY $3.32
- BDTX $2.48
- Analyst Decision
- AMPY Strong Buy
- BDTX Strong Buy
- Analyst Count
- AMPY 2
- BDTX 6
- Target Price
- AMPY $10.25
- BDTX $14.83
- AVG Volume (30 Days)
- AMPY 1.4M
- BDTX 1.4M
- Earning Date
- AMPY 08-06-2025
- BDTX 08-05-2025
- Dividend Yield
- AMPY N/A
- BDTX N/A
- EPS Growth
- AMPY N/A
- BDTX N/A
- EPS
- AMPY 0.39
- BDTX 0.09
- Revenue
- AMPY $290,431,100.00
- BDTX $70,000,000.00
- Revenue This Year
- AMPY $2.88
- BDTX N/A
- Revenue Next Year
- AMPY $50.86
- BDTX N/A
- P/E Ratio
- AMPY $8.31
- BDTX $28.38
- Revenue Growth
- AMPY N/A
- BDTX N/A
- 52 Week Low
- AMPY $2.27
- BDTX $1.20
- 52 Week High
- AMPY $8.15
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- AMPY 46.50
- BDTX 57.54
- Support Level
- AMPY $3.18
- BDTX $2.34
- Resistance Level
- AMPY $3.56
- BDTX $2.71
- Average True Range (ATR)
- AMPY 0.25
- BDTX 0.17
- MACD
- AMPY -0.05
- BDTX -0.02
- Stochastic Oscillator
- AMPY 2.60
- BDTX 58.93
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.